Comparison between technetium-99m-teboroxime and thallium-201 dipyridamole planar myocardial perfusion imaging in detection of coronary artery disease
-
Add time:08/23/2019 Source:sciencedirect.com
Technetium-99m (TC-99m)-teboroxime is a new myocardial perfusion imaging agent. The purpose of this prospective study was to compare Tc-99m-teboroxime with thallium-201 imaging after the administration of dipyridamole. Thirty patients referred for the evaluation of chest pain were studied with both thallium-201 and Tc-99m-teboroxime dipyridamole scans (mean interval 2 days). Dipyridamole was administered at 0.142 mg/kg/min for 4 minutes. Planar imaging (3 standard views) was obtained at S and 240 minutes after the injection of 2.2 mCl of thallium-201. Tc-99m-teboroxime (18 to 25 mCi) was infected after dipyridamole infusion. A second injection, at rest, was repeated 4 hours later. Planar imaging (3 standard views of 1 minute/view for the first 2 views, and 90 seconds for the last view) was obtained 2 minutes after Tc-99m-teboroxime injection. Blinded reading was performed by 3 observers. Thallium-201 showed perfusion defects in 182 myocardial segments corresponding to 33 of 45 (73%) significantly stenosed coronary arteries (≥70% reduction in endoluminal diameter), and Tc-99m-teboroxime detected 160 abnormal segments corresponding to 29 of 45 (64%) stenosed arteries. Thallium-201 and Tc-99m-teboroxime studies were normal in 3 patients. In conclusion, this study shows that there is a good correlation in the imaging results found with thallium-201 and Tc-99m-teboroxime using dipyridamole infusion on both a segmental and a diagnostic comparison.
We also recommend Trading Suppliers and Manufacturers of TECHNETIUM TEBOROXIME (cas 100995-86-6). Pls Click Website Link as below: cas 100995-86-6 suppliers
Prev:Experimental studyMyocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion
Next:N-demethylation of N-methyl-4-aminoantipyrine, the main metabolite of metamizole) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Experimental studyMyocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion08/22/2019
- MethodTomographic myocardial perfusion imaging with technetium-99m teboroxime during adenosine-induced coronary hyperemia: Correlation with thallium-201 imaging☆08/21/2019
- Progress in cardiologyDynamic planar myocardial perfusion imaging in patients with one-vessel disease with intracoronary injection of technetium 99m teboroxime during papaverine-induced coronary hyperemia08/20/2019
- The Canadian exercise technetium 99m-labeled teboroxime single-photon emission computed tomographic study+08/19/2019
- Technetium-99m teboroxime regional myocardial washout in subjects with and without coronary artery disease☆08/18/2019
- Experimental studyThe relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow☆08/17/2019
- Clinical experience with technetium 99m teboroxime08/16/2019


